Literature DB >> 15645611

Molecular mechanisms of acute renal failure following ischemia/reperfusion.

A M G Versteilen1, F Di Maggio, J R Leemreis, A B J Groeneveld, R J P Musters, P Sipkema.   

Abstract

Acute renal failure (ARF) necessitating renal replacement therapy is a common problem associated with high morbidity and mortality in the critically ill. Hypotension, followed by resuscitation, is the most common etiologic factor, mimicked by ischemia/reperfusion (I/R) in animal models. Although knowledge of the pathophysiology of ARF in the course of this condition is increasingly detailed, the intracellular and molecular mechanisms leading to ARF are still incompletely understood. This review aims at describing the role of cellular events and signals, including collapse of the cytoskeleton, mitochondrial and nuclear changes, in mediating cell dysfunction, programmed cell death (apoptosis), necrosis and others. Insight into the molecular pathways in the various elements of the kidney, such as vascular endothelium and smooth muscle and tubular epithelium leading to cell damage upon I/R will, hopefully, open new therapeutic modalities, to mitigate the development of ARF after hypotensive episodes and to promote repair and resumption of renal function once ARF has developed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15645611     DOI: 10.1177/039139880402701203

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  19 in total

1.  Hydrogen sulfide treatment ameliorates long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury.

Authors:  Ian Lobb; Justin Zhu; Weihua Liu; Aaron Haig; Zhu Lan; Alp Sener
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 2.  Cell adhesion molecules in chemically-induced renal injury.

Authors:  Walter C Prozialeck; Joshua R Edwards
Journal:  Pharmacol Ther       Date:  2007-01-23       Impact factor: 12.310

3.  Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury.

Authors:  Carla Q Feitoza; Patricia Semedo; Giselle M Gonçalves; Marcos A Cenedeze; Hélady S Pinheiro; Oscar Fernando Pavão Dos Santos; Richardt Gama Landgraf; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Inflamm Res       Date:  2009-08-27       Impact factor: 4.575

4.  GSK3beta promotes apoptosis after renal ischemic injury.

Authors:  Zhiyong Wang; Andrea Havasi; Jonathan Gall; Ramon Bonegio; Zhijian Li; Haiping Mao; John H Schwartz; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

Review 5.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

6.  Late intervention with the small molecule BB3 mitigates postischemic kidney injury.

Authors:  Prakash Narayan; Bin Duan; Kai Jiang; Jingsong Li; Latha Paka; Michael A Yamin; Scott L Friedman; Matthew R Weir; Itzhak D Goldberg
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-01

7.  TMIGD1 is a novel adhesion molecule that protects epithelial cells from oxidative cell injury.

Authors:  Emad Arafa; Philip A Bondzie; Kobra Rezazadeh; Rosana D Meyer; Edward Hartsough; Joel M Henderson; John H Schwartz; Vipul Chitalia; Nader Rahimi
Journal:  Am J Pathol       Date:  2015-09-02       Impact factor: 4.307

8.  Hypoxic pre-conditioning in a rat renal ischemia model: an evaluation of the use of hydralazine.

Authors:  Catherine Michels; Thambi Dorai; Praveen Chander; Muhammad Choudhury; Michael Grasso
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

9.  AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.

Authors:  Akbar Ahmad; Gabor Olah; Bartosz Szczesny; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Shock       Date:  2016-01       Impact factor: 3.454

10.  Glycyrrhizin protects mice against renal ischemia-reperfusion injury through inhibition of apoptosis and inflammation by downregulating p38 mitogen-activated protein kinase signaling.

Authors:  Shaojun Ye; Yi Zhu; Yingzi Ming; Xingguo She; Hong Liu; Qifa Ye
Journal:  Exp Ther Med       Date:  2014-02-21       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.